Bluestone Pharma GmbH – Trademark Portfolio

Entity Type: 99

Bluestone Pharma GmbH holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LIVETAB, RHINOZYN, and DSM 34540.

Rathausstr. 14

CH-6340 Baar

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DSM 34540
DSM 34540
Registered 2023
LIVETAB
LIVETAB
Registered 2022
RHINOZYN
RHINOZYN
Registered 2019
K-12
K-12
Abandoned 2018

Trademark Classifications

Bluestone Pharma GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Bluestone Pharma GmbH have?

Bluestone Pharma GmbH has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned.

What trademark classes does Bluestone Pharma GmbH file in?

Bluestone Pharma GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Bluestone Pharma GmbH's most well-known trademarks?

Bluestone Pharma GmbH's registered trademark portfolio includes well-known marks such as LIVETAB, RHINOZYN, and DSM 34540. These are among 3 currently registered trademarks in the portfolio.

What is Bluestone Pharma GmbH's trademark registration success rate?

Bluestone Pharma GmbH has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.